Catalyst Pharmaceuticals Q1 Adj $0.38 Beats $0.17 Estimate, Sales $98.51M Beat $98.13M Estimate
Author: Benzinga Newsdesk | May 08, 2024 04:22pm
Catalyst Pharmaceuticals (NASDAQ:
CPRX) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.17 by 123.53 percent. This is a 7.32 percent decrease over earnings of $0.41 per share from the same period last year. The company reported quarterly sales of $98.51 million which beat the analyst consensus estimate of $98.13 million by 0.39 percent. This is a 15.40 percent increase over sales of $85.37 million the same period last year.
Posted In: CPRX